This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Dec 12;391(23):2273-2274.

doi: 10.1056/NEJMc2413296.

Four Years of Screening for Prostate Cancer with PSA and MRI

Derya Tilki¹, Ming-Hui Chen², Anthony V D'Amico³

Affiliations

Affiliations

¹ University Hospital Hamburg-Eppendorf, Hamburg, Germany.
² University of Connecticut, Storrs, CT.
³ Brigham and Women's Hospital, Boston, MA adamico@bwh.harvard.edu.

PMID: 39665660
DOI: 10.1056/NEJMc2413296

Comment

Four Years of Screening for Prostate Cancer with PSA and MRI

Derya Tilki et al. N Engl J Med. 2024.

. 2024 Dec 12;391(23):2273-2274.

doi: 10.1056/NEJMc2413296.

Authors

Derya Tilki¹, Ming-Hui Chen², Anthony V D'Amico³

Affiliations

¹ University Hospital Hamburg-Eppendorf, Hamburg, Germany.
² University of Connecticut, Storrs, CT.
³ Brigham and Women's Hospital, Boston, MA adamico@bwh.harvard.edu.

PMID: 39665660
DOI: 10.1056/NEJMc2413296

No abstract available

PubMed Disclaimer

Comment on

Results after Four Years of Screening for Prostate Cancer with PSA and MRI.
Hugosson J, Godtman RA, Wallstrom J, Axcrona U, Bergh A, Egevad L, Geterud K, Khatami A, Socratous A, Spyratou V, Svensson L, Stranne J, Månsson M, Hellstrom M. Hugosson J, et al. N Engl J Med. 2024 Sep 26;391(12):1083-1095. doi: 10.1056/NEJMoa2406050. N Engl J Med. 2024. PMID: 39321360 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal